Advertisement

Updated Guidelines for Preventing Recurrent Stroke — Physician’s First Watch

Medical News |
May 2, 2014

Updated Guidelines for Preventing Recurrent Stroke

By Kelly Young

The American Heart Association and the American Stroke Association have released updated guidelines for preventing recurrent stroke in patients who've experienced a stroke or transient ischemic attack.

Here are a few of the changes from the groups' 2011 guidelines:

  • Systolic blood pressure below 140 mm Hg and diastolic pressure below 90 mm Hg are reasonable goals.

  • Vitamin K antagonist therapy, apixaban, and dabigatran are indicated to prevent recurrent stroke in patients who have nonvalvular atrial fibrillation, while rivaroxaban is considered a reasonable option.

  • For patients over age 70, carotid endarterectomy may have better outcomes than carotid angioplasty with stenting. In younger patients, the two approaches are similar in their risks for perioperative complications and long-term ipsilateral stroke.

Additional recommendations on medical and surgical management are included.

Reader Comments (1)

Almeida, Joao, MD Physician, Dentistry

Stay informed on the eventual changing ...

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement